| DC Field | Value | Language |
|---|
| dc.contributor.author | Mutiara Indah Sari | - |
| dc.contributor.author | Imam Budi Putra | - |
| dc.contributor.author | Dadik Wahyu Wijaya | - |
| dc.date.accessioned | 2023-10-03T12:07:19Z | - |
| dc.date.available | 2023-10-03T12:07:19Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Mutiara Indah Sari. The therapeutic potential of mesenchymal stem cells in COVID-19: Present and future / Mutiara Indah Sari, Imam Budi Putra, Dadik Wahyu Wijaya // Research Results in Pharmacology. - 2023. - Vol.9, №2.-P. 75-84. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/56833 | - |
| dc.description.abstract | Mesenchymal stem cells (MSCs) have been widely studied for their anti-inflammatory and immunomodulatory effects as COVID-19 treatment and shown their potential to improve the condition of COVID-19 patients. This systematic review aims to assess the therapeutic potential of MSCs as antiinflammatory and immunomodulatory agent in COVID-19 | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | anti-inflammatory | ru |
| dc.subject | cell therapy | ru |
| dc.subject | immunomodulatory | ru |
| dc.subject | inflammation | ru |
| dc.subject | virus | ru |
| dc.subject | Coronavirus disease 2019 | ru |
| dc.title | The therapeutic potential of mesenchymal stem cells in COVID-19: Present and future | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 2
|
